Myeloma Research and News

How the Total Eclipse Offers Proof Positive That Science Is Not Fake News

This week’s eclipse occurred exactly when, where, and how scientists said it would—powerful proof, says IMF Chairman Dr. Brian Durie, that scientific “truth has consequences.” Whether the subject is climate change or a myeloma research breakthrough, science provides “an extraordinary tool to understand the world around us, from the planets and stars above, to the molecules within every cell of our bodies.” Read Dr. Durie’s blog.

Register Now for a Free Webinar on Myeloma Tests and Results

Join the IMF’s Medical Editor Debbie Birns for a “Living Well with Myeloma” webinar on Making Sense of Tests and Results. Debbie will outline the various tests that are used to diagnose myeloma, monitor response to treatment, and detect side effects. This sixty-minute webinar occurs on Thursday, September 14th, 2017 at 4 PM PT / 7 PM ET and includes a question-and-answer session. Pre-register today for FREE.

Meta-Analysis Shows Benefits for Newly Diagnosed Myeloma Patients Who Use Revlimid for Maintenance After Transplant

This abstract in the Journal of Clinical Oncology explains that newly diagnosed myeloma patients who undergo an autologous stem cell transplant and follow it up with Revlimid® (lenalidomide) maintenance, have longer progression-free survival and a significant overall survival benefit.

Scottish Medicines Consortium Approves Kyprolis for Combination Treatment

Myeloma UK reports myeloma patients can now access Kyprolis® (carfilzomib) in combination with dexamethasone. This combination is available to multiple myeloma patients who have received at least one prior therapy. This decision was based on results from last July’s ENDEAVOR Phase 3 trial (NCT01568866).

How to FUNdraise for the IMF Without Leaving Your Home

In past newsletters, you have probably heard about the IMF’s Member FUNdraisers. However, you may be too busy to plan an event. Here’s a simple way you can raise myeloma awareness and funding without leaving your home: the IMF’s Letter-Writing Campaign. Contact Suzanne Battaglia at sbattaglia@myeloma.org or (800) 452-2873. Suzanne will provide you with the letter template to send to your mail or email contacts. No amount you raise is too big or too small! 

What is the best way to manage recurrent lung infections?

In this week’s video, Dr. Brian Durie explains some the different causes of lung infections and how to possibly treat each kind. 

 

 


We Thank Our Sponsors: Amgen, Celgene Corporation, Genentech, Janssen Pharmaceuticals, and Takeda Oncology